Nymox Pharmaceutical
NYMX
#10189
Rank
โ‚ฌ15.67 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -0,05734ย โ‚ฌ

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -0,05153ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,06871ย โ‚ฌ an increase over its 2021 EPS that were of -0,13ย โ‚ฌ.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,05734ย โ‚ฌ-16.56%
2022-0,06871ย โ‚ฌ-46.67%
2021-0,13ย โ‚ฌ-11.76%
2020-0,15ย โ‚ฌ-15%
2019-0,17ย โ‚ฌ5.26%
2018-0,16ย โ‚ฌ-26.92%
2017-0,22ย โ‚ฌ-7.14%
2016-0,24ย โ‚ฌ-40.43%
2015-0,40ย โ‚ฌ291.67%
2014-0,10ย โ‚ฌ-7.69%
2013-0,11ย โ‚ฌ-43.48%
2012-0,20ย โ‚ฌ-25.81%
2011-0,27ย โ‚ฌ55%
2010-0,17ย โ‚ฌ25%
2009-0,14ย โ‚ฌ0.08%
2008-0,14ย โ‚ฌ-11.12%
2007-0,15ย โ‚ฌ-0.16%
2006-0,15ย โ‚ฌ28.59%
2005-0,12ย โ‚ฌ-12.49%
2004-0,14ย โ‚ฌ-16.05%
2003-0,16ย โ‚ฌ19.07%
2002-0,14ย โ‚ฌ14.45%
2001-0,12ย โ‚ฌ-22.16%
2000-0,15ย โ‚ฌ7.67%
1999-0,14ย โ‚ฌ-34.59%
1998-0,22ย โ‚ฌ-3.6%
1997-0,23ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
6,92ย โ‚ฌ-13,528.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,48ย โ‚ฌ-2,966.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
7,42ย โ‚ฌ-14,500.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
17,62ย โ‚ฌ-34,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-17,499.00%๐Ÿ‡บ๐Ÿ‡ธ USA